Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DXR - Daxor Corp.


IEX Last Trade
8.1
-1.600   -19.753%

Share volume: 15,968
Last Updated: Fri 30 Aug 2024 09:56:27 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$9.70
-1.60
-16.50%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
1.76%
1 Month
-4.91%
3 Months
-6.53%
6 Months
13.42%
1 Year
-13.20%
2 Year
-37.96%
Key data
Stock price
$8.10
P/E Ratio 
0.00
DAY RANGE
$8.01 - N/A
EPS 
$0.00
52 WEEK RANGE
$7.11 - $10.04
52 WEEK CHANGE
-$0.13
MARKET CAP 
40.872 M
YIELD 
N/A
SHARES OUTSTANDING 
4.837 M
DIVIDEND
$0.03
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$11,081
AVERAGE 30 VOLUME 
$7,386
Company detail
CEO:
Region: US
Website: daxor.com
Employees: 36
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.

Recent news